Pettersen, EO, Ebbesen, P, Gieling, RG, Williams, KJ
, Dubois, L, Lambin, P, Ward, C, Meehan, J, Kunkler, IH, Langdon, SP, Ree, AH, Flatmark, K, Lyng, H, Calzada, MJ, del Peso, L, Landazuri, MO, Goerlach, A, Flamm, H, Kieninger, J, Urban, G, Weltin, A, Singleton, DC, Haider, S, Buffa, FM, Harris, AL, Scozzafava, A, Supuran, CT, Moser, I, Jobst, G, Busk, M, Toustrup, K, Overgaard, J, Alsner, J, Pouyssegur, J, Chiche, J, Mazure, N, Marchiq, I, Parks, S, Ahmed, A, Ashcroft, M, Pastorekova, S, Cao, Y
, Rouschop, KM, Wouters, BG, Koritzinsky, M, Mujcic, H & Cojocari, D 2015, '
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium',
Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 30, no. 5, pp. 689-721.
https://doi.org/10.3109/14756366.2014.966704